Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington.
Biol Blood Marrow Transplant. 2020 Dec;26(12):e309-e312. doi: 10.1016/j.bbmt.2020.09.001. Epub 2020 Sep 12.
Hematopoietic cell transplantation generates new individuals, transplant chimeras, composed of 2 genetic partners-the patient and donor-derived cells-no longer restricted by their original genomes. Interactions of donor-derived and recipient cells occur prominently at the boundary of the recipient with a third partner, the microbiome, in particular skin and intestinal tract, leading to disruption of microbiome homeostasis. These interactions of donor and patient cells at the boundary set the stage for the development of graft-versus-host disease, an expression of the defense of individuality by recipient and donor. Establishment of tolerance and return of homeostasis at the boundary will allow for the survival of the new integrated, physiologic individual.
造血细胞移植产生新的个体,即移植嵌合体,由 2 个遗传伙伴组成——患者和供者来源的细胞——不再受其原始基因组的限制。供者来源的细胞和受者细胞之间的相互作用在受者与第三个伙伴——微生物群,特别是皮肤和肠道——的边界处显著发生,导致微生物群的动态平衡被打破。供者和患者细胞在边界处的这些相互作用为移植物抗宿主病的发展奠定了基础,这是受者和供者对个体性的防御的一种表现。在边界处建立耐受和恢复动态平衡将允许新的整合的生理个体的存活。